About Actin-like protein 6B
Actin-like protein 6B (ACTL6B) is a protein
from Homo sapiens identified by UniProt accession
O94805, 426 residues long.
MolForge cross-references it against 0 known binders and
87 disease associations.
Target properties
| Protein name | Actin-like protein 6B |
| UniProt accession | O94805 |
| Gene | ACTL6B |
| Organism | Homo sapiens |
| Length | 426 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (87)
Diseases linked to this target (Open Targets).
- developmental and epileptic encephalopathy · score 0.68
- autosomal dominant non-syndromic intellectual disability · score 0.62
- autism spectrum disorder · score 0.50
- Intellectual disability · score 0.41
- genetic disorder · score 0.41
- complex neurodevelopmental disorder · score 0.37
- undetermined early-onset epileptic encephalopathy · score 0.37
- autism · score 0.32
- Global developmental delay · score 0.27
- breast adenocarcinoma · score 0.24
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O94805-F1 | alphafold | PREDICTED | 91.01 | — |
Amino-acid sequence (426 residues)
MSGGVYGGDE VGALVFDIGS FSVRAGYAGE DCPKADFPTT VGLLAAEEGG GLELEGDKEK KGKIFHIDTN ALHVPRDGAE VMSPLKNGMI EDWECFRAIL DHTYSKHVKS EPNLHPVLMS EAPWNTRAKR EKLTELMFEQ YNIPAFFLCK TAVLTAFANG RSTGLVLDSG ATHTTAIPVH DGYVLQQGIV KSPLAGDFIS MQCRELFQEM AIDIIPPYMI AAKEPVREGA PPNWKKKEKL PQVSKSWHNY MCNEVIQDFQ ASVLQVSDSP YDEQVAAQMP TVHYEMPNGY NTDYGAERLR IPEGLFDPSN VKGLSGNTML GVGHVVTTSI GMCDIDIRPG LYGSVIVTGG NTLLQGFTDR LNRELSQKTP PSMRLKLIAS NSTMERKFSP WIGGSILASL GTFQQMWISK QEYEEGGKQC VERKCP
Explore Actin-like protein 6B with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets